n
membranebound
metalloproteinas
implic
human
cytomegaloviru
hcmv
infect
pathogenesi
antibodi
neutral
hcmv
infect
hcmv
viremia
bone
marrow
transplant
induc
autoantibodi
correl
develop
chronic
graft
vs
host
diseas
examin
whether
murin
similarli
implic
murin
cytomegaloviru
mcmv
diseas
mcmv
infect
induc
antibodi
mice
strainspecif
manner
icr
mice
develop
high
titer
antibodi
antimcmv
antibodi
mcmv
infect
wherea
cba
hybrid
mice
produc
antibodi
mcmv
unlik
hcmv
evid
found
correl
host
cell
express
infect
presenc
mcmv
particl
although
apn
inhibitor
decreas
mcmv
plaqu
format
reproduct
autoantibodi
product
murin
system
make
possibl
determin
antibodi
contribut
cmv
pathogenesi
cytomegalovirus
betaherpesvirus
establish
lifelong
infect
host
sever
find
implic
also
known
aminopeptidas
n
apn
human
cytomegaloviru
hcmv
infect
pathogenesi
seri
bone
marrow
transplant
patient
autoantibodi
found
patient
confirm
cmv
diseas
transplant
highli
associ
later
develop
chronic
graft
vs
host
diseas
cgvhd
soderberg
et
al
soderberg
et
al
patient
seroposit
cmv
neg
presenc
viru
develop
antibodi
cgvhd
soderberg
et
al
molecular
level
sever
group
shown
human
cmv
incorpor
host
cell
protein
one
apn
viral
envelop
hommanloudiyi
et
al
michelson
et
al
naucler
et
al
wright
et
al
monoclon
antibodi
rais
apn
neutral
human
cmv
viral
particl
immunoblot
purifi
human
cmv
virion
detect
soderberg
et
al
viral
particl
label
antibodi
immunogold
particl
later
seen
surfac
infect
cell
giugni
et
al
consist
viral
sequestr
cell
surfac
downregul
human
cmv
infect
fibroblast
phillip
et
al
associ
viral
particl
suggest
mechan
gener
antibodi
cmv
infect
autoimmun
naucler
et
al
virusassoci
essenti
hcmv
infect
suggest
antibodi
inhibit
infect
soderberg
et
al
howev
human
neuroblastoma
cell
lack
express
suscept
hcmv
infect
watanab
recent
epiderm
growth
factor
receptor
shown
import
mediat
hcmv
entri
cell
wang
et
al
membranebound
metalloproteinas
wide
express
mammalian
cell
includ
monocyt
macrophag
endotheli
cell
epitheli
cell
fibroblast
curni
et
al
phillip
et
al
plakidoudymock
et
al
riemann
et
al
exist
heavili
glycosyl
homodim
constitut
activ
proteinas
activ
extern
plasma
membran
riemann
et
al
addit
numer
tissuespecif
function
serv
major
receptor
type
coronavirus
breslin
et
al
yeager
et
al
includ
possibl
sar
viru
yu
et
al
recent
shown
import
mediat
angiogenesi
express
endotheli
cell
nascent
blood
vessel
bhagwat
et
al
antibodi
rais
inhibitor
aminopeptidas
activ
block
angiogenesi
model
neovascular
pasqualini
et
al
may
signific
regard
cmv
sinc
cmv
infect
associ
mani
chronic
vascular
diseas
borcher
et
al
hamamdz
et
al
nieto
et
al
pandey
leroy
cmvinduc
apn
antibodi
may
repres
one
mechan
viru
initi
vascular
patholog
like
herpesvirus
cytomegalovirus
speci
specif
link
cmv
vascular
diseas
seen
human
reproduc
repeatedli
mice
infect
murin
cytomegaloviru
berencsi
et
al
hamamdz
et
al
hummel
et
al
presti
et
al
therefor
studi
examin
whether
also
implic
mcmv
infect
mice
four
mous
strain
test
induct
mcmv
immun
mcmv
infect
strain
cba
hybrid
icr
mice
defici
interferon
gamma
receptor
vari
haplotyp
report
resist
mcmv
infect
group
anim
strain
infect
pfu
mcmv
ip
inject
subleth
dose
adult
anim
strain
serum
collect
day
analyz
elisa
igg
antibodi
mcmv
mous
strain
similar
level
igg
antibodi
direct
mcmv
fig
howev
antibodi
detect
sera
icr
mice
detect
antibodi
found
sera
cba
hybrid
mice
antibodi
human
report
peopl
develop
hcmv
viremia
immunocompromis
state
order
test
whether
immunocompromis
state
would
associ
induct
higher
level
antibodi
mice
cyclosporin
awa
use
induc
immunocompromis
state
icr
mice
three
group
icr
mice
treat
either
cyclosporin
alon
cyclosporin
pfu
mcmv
pfu
mcmv
mock
cyclosporin
inject
mice
treat
cyclosporin
mcmv
increas
sign
ill
given
mcmv
alon
shown
howev
level
antibodi
mcmv
significantli
differ
two
group
fig
investig
whether
express
murin
correl
mcmv
suscept
report
hcmv
soderberg
et
al
soderberg
et
al
five
murin
cell
line
character
respect
mcmv
progeni
product
cell
surfac
aminopeptidas
activ
nih
primari
mous
embryon
fibroblast
mef
fibroblast
phenotyp
cell
mous
endotheli
cell
line
immort
polyoma
antigen
tantigen
respect
duboi
et
al
oconnel
edidin
assay
mcmv
progeni
product
inocul
low
multipl
infect
mark
differ
seen
cell
line
suscept
product
mcmv
infect
fig
peak
mcmv
titer
supernat
three
fibroblast
line
close
pfuml
cell
produc
pfuml
cell
produc
less
pfuml
similar
rel
result
seen
plaqu
assay
five
cell
line
fig
contrast
human
cell
attempt
compar
apn
express
murin
cell
line
immunolog
method
unsuccess
two
commerci
avail
antibodi
specif
murin
fail
recogn
protein
western
blot
cell
extract
shown
immunofluoresc
flow
cytometri
stain
cell
surfac
protein
antibodi
conjug
phycoerythrin
show
present
endotheli
fibroblast
cell
howev
rel
express
compar
method
differ
cell
type
altern
immunolog
techniqu
use
quantit
cell
surfac
apn
enzymat
activ
measur
standard
procedur
use
colorimetr
substrat
alapnitroanalid
hydrochlorid
plakidoudymock
et
al
determin
linear
assay
adher
cell
mef
cell
plate
densiti
cellswel
incub
h
later
adher
monolay
apn
substrat
substrat
convers
directli
proport
number
cell
cell
line
fig
slight
decreas
higher
densiti
expect
cell
plate
cellswel
plate
subsequ
assay
compar
amount
cellsurfac
expos
mcmv
standard
inocul
subsequ
plaqu
format
parallel
set
well
cell
type
assay
apn
enzym
activ
inocul
mcmvlacz
incub
h
follow
stain
count
plaqu
three
dilut
mcmvlacz
viru
use
three
set
well
detect
rang
suscept
observ
correl
express
mcmv
plaqu
format
fig
apn
enzym
activ
similar
five
cell
line
wherea
plaqu
format
progeni
viru
product
markedli
differ
especi
endotheli
fibroblast
cell
whether
necessari
mcmv
infect
determin
experi
sinc
none
murin
cell
line
test
neg
howev
express
clearli
suffici
product
mcmv
infect
endotheli
cell
edta
monohydr
apn
inhibitor
act
chelat
dival
metal
effect
concentr
effect
caus
adher
cell
cell
lift
therefor
cell
purpos
incub
mcmvlacz
viru
suspens
presenc
absenc
apn
inhibitor
incub
cell
wash
clean
unbound
viru
inhibitor
plate
plaqu
visual
h
postinfect
xgal
count
parallel
well
treatment
edta
significantli
decreas
number
plaqu
form
treat
cell
dosedepend
manner
fig
exposur
concentr
mm
edta
mm
h
kill
cell
contrast
viru
expos
inhibitor
concentr
min
prior
dilut
inocul
cell
fig
effect
cyclosporin
treatment
antibodi
induct
mcmv
infect
sera
femal
icr
mice
analyz
antimcmv
gray
bar
black
bar
igg
antibodi
elisa
group
mice
inject
cyclosporin
csa
daili
day
diluent
daili
day
inocul
pfu
mcmvlacz
day
csa
daili
day
equival
amount
uninfect
salivari
gland
extract
day
treatment
intraperiton
inject
sera
collect
day
dilut
salin
analyz
duplic
result
express
fold
increas
antibodi
level
rel
mean
respons
mice
treat
csa
alon
littl
effect
seen
plaqu
format
indic
mcmv
particl
depend
metalloproteinas
activ
stabil
activ
fig
detect
antibodi
hcmv
viral
envelop
antibodi
neutral
human
cmv
prevent
infect
vitro
giugni
et
al
antimurin
antibodi
test
abil
block
mcmv
infect
cell
neither
preincub
antibodi
viru
antibodi
host
cell
reduc
plaqu
format
fig
b
sinc
epitop
give
rise
neutral
antibodi
hcmv
giugni
et
al
rule
role
apn
mcmv
infect
strang
presenc
antibodi
infect
significantli
enhanc
number
size
plaqu
form
cell
fig
antibodi
similar
effect
preincub
viru
fig
although
antibodydepend
enhanc
viral
infect
well
document
gener
requir
antibodi
speci
host
cell
depend
fc
complement
receptor
express
host
cell
tirado
yoon
rat
rabbit
antibodi
respect
nih
cell
known
express
fc
receptor
two
method
use
attempt
detect
apn
incorpor
mcmv
viral
particl
apn
activ
assay
salivari
glandderiv
viru
vs
uninfect
salivari
gland
supernat
compar
found
ident
normal
protein
content
tabl
addit
salivari
glandderiv
mcmv
tissu
culturederiv
mcmv
relev
uninfect
control
extract
murin
brush
border
membran
vesicl
bbmv
spot
onto
nitrocellulos
sever
dilut
probe
antibodi
antibodi
readili
detect
dilut
bbmv
fail
detect
protein
viral
control
prepar
dilut
data
shown
summari
evid
incorpor
mcmv
viral
envelop
found
fig
mcmv
suscept
correl
cell
surfac
aminopeptidas
activ
five
murin
cell
line
primari
embryon
fibroblast
mef
seed
well
plate
cellswel
allow
adher
overnight
six
well
cell
type
immedi
assay
cell
surfac
apn
activ
parallel
well
cell
type
expos
mcmvlacz
viru
incub
viru
inoculum
replac
fresh
medium
two
day
later
plaqu
visual
xgal
overlay
titer
light
bar
express
mean
plaqu
per
well
rel
apn
activ
dark
bar
indic
absorb
unit
right
yaxi
figur
repres
two
ident
experi
human
cmv
report
reduc
express
infect
human
fibroblast
approxim
within
h
infect
determin
immunofluoresc
stain
apn
activ
assay
express
reduc
next
day
infect
appear
due
er
retent
degrad
protein
phillip
et
al
determin
mcmv
similar
effect
murin
apn
cell
five
murin
cell
line
assay
apn
activ
h
infect
cell
infect
moi
approxim
mock
infect
equival
concentr
salivari
gland
homogen
uninfect
mice
contrast
human
fibroblast
three
mous
fibroblast
line
slightli
increas
apn
cell
surfac
activ
h
infect
mous
endotheli
cell
line
slightli
decreas
apn
activ
fig
h
cell
death
appar
infect
well
apn
activ
reduc
compar
mockinfect
well
howev
apn
activ
per
well
increas
compar
h
postinfect
case
due
increas
cell
number
shown
whole
cell
elisa
gave
similar
result
except
differ
infect
noninfect
cell
even
smaller
shown
therefor
unlik
human
cmv
infect
mcmv
infect
seem
small
effect
express
fibroblast
endotheli
cell
vari
accord
cell
type
agreement
previou
report
human
cmv
infect
induc
antibodi
immunocompromis
individu
found
murin
cmv
induc
antibodi
murin
suscept
strain
mice
howev
treatment
suscept
mice
immunosuppress
cyclosporin
significantli
increas
antibodi
product
suggest
immunosuppress
necessari
induct
autoantibodi
whether
immunocompet
human
develop
antibodi
cmv
infect
investig
knowledg
strain
produc
highest
ratio
antimcmv
antibodi
use
model
persist
cmv
infect
mice
activ
shed
viru
least
month
infect
presti
et
al
contrast
cba
hybrid
known
genet
resist
mcmvinduc
mortal
mcmv
resist
mice
determin
larg
gene
encod
nk
cell
receptor
activ
mcmv
protein
aras
et
al
lee
et
al
swihart
et
al
mcmvresist
mous
strain
peak
spleen
viral
titer
log
lower
ld
dose
log
higher
suscept
strain
cba
mice
express
nk
cell
resist
wherea
mice
express
suscept
icr
mice
genotyp
intermedi
suscept
mcmv
morbid
well
autoantibodi
product
suggest
high
spleen
titer
may
associ
develop
antibodi
mhc
type
seem
correl
antibodi
product
experi
sinc
haplotyp
b
share
product
nonproduct
hybrid
strain
human
system
propos
antibodi
occur
result
autoimmun
incorpor
hcmv
viral
envelop
unabl
find
evid
incorpor
mcmv
viral
particl
may
due
limit
varieti
antibodi
avail
murin
system
neither
antibodi
test
abl
detect
western
blot
fail
detect
even
nativ
bbmv
contain
apn
readili
detect
dilut
antibodi
possibl
comprehens
array
antimurin
antibodi
would
detect
mcmv
particl
abl
neutral
mcmv
infect
howev
apn
enzymat
assay
also
fail
detect
differ
viru
control
lysat
cellsurfac
also
correl
mcmv
suscept
inhibitor
apn
enzym
activ
reduc
mcmv
plaqu
format
inhibitor
use
especi
specif
apn
taken
togeth
role
entri
mediat
mcmv
seem
unlik
virusinduc
autoantibodi
includ
antiendotheli
cell
antiphospholipid
antibodi
follow
cytomegaloviru
infect
demonstr
fig
cell
surfac
apn
activ
significantli
alter
mcmv
infect
parallel
well
cell
line
mock
infect
gray
bar
infect
mcmvlacz
moi
black
bar
h
infect
cell
surfac
apn
activ
measur
alapnitroalanin
cleavag
addit
apn
inhibitor
stripe
bar
substrat
use
posit
control
mice
human
bartholomaeu
et
al
cheng
khairullah
fairweath
et
al
hebart
et
al
hiemstra
et
al
lipe
et
al
lunardi
et
al
regard
mechan
induct
propos
antibodi
direct
viral
antigen
coincid
resembl
host
cellular
protein
molecular
mimicri
virusinduc
tissu
damag
result
immunolog
process
recognit
selfantigen
normal
sequest
immun
surveil
lawson
naucler
et
al
studi
sever
factor
argu
simpl
case
molecular
mimicri
although
human
mous
ident
amino
acid
level
chen
et
al
hcmv
mcmv
share
less
homolog
glycosyl
genet
polymorph
vijgen
et
al
wentworth
holm
predict
mhc
present
peptid
differ
mhc
haplotyp
speci
therefor
likelihood
singl
epitop
common
host
virus
present
sever
mhc
type
seem
small
determin
epitop
recogn
sera
differ
mous
strain
current
underway
may
allow
identif
viral
antigen
induc
molecular
mimicri
lead
product
antibodi
immunolog
process
selfantigen
result
virusinduc
tissu
damag
difficult
examin
associ
autoantibodi
condit
favor
high
vivo
titer
consist
mechan
howev
credibl
describ
sequest
selfantigen
normal
express
surfac
numer
cell
type
throughout
bodi
present
normal
serum
kawai
et
al
therefor
neither
gener
mechan
thought
give
rise
virusinduc
autoantibodi
seem
like
case
mcmvinduc
antibodi
cmv
seroposit
long
associ
varieti
vasculopathi
includ
atherosclerosi
system
sclerosi
borcher
et
al
hamamdz
et
al
nieto
et
al
pandey
leroy
cmv
infect
also
long
recogn
seriou
complic
bone
marrow
solid
organ
transplant
vascular
sequela
borcher
et
al
matthesmartin
et
al
cmv
viremia
bone
marrow
transplant
associ
signific
increas
chronic
graft
vs
host
diseas
cgvhd
share
mani
featur
common
autoimmun
diseas
scleroderma
begin
inflamm
destruct
small
blood
vessel
pandey
leroy
cmv
viremia
solid
organ
transplant
result
exacerb
transplant
vascular
sclerosi
lead
chronic
graft
reject
borcher
et
al
mechan
cmv
produc
neg
outcom
understood
howev
reduct
viral
titer
antivir
drug
decreas
cgvhd
cmvassoci
reject
vascular
stenosi
koskinen
et
al
matthesmartin
et
al
autoantibodi
target
angiogen
factor
may
one
mechan
cmv
could
mediat
effect
two
mous
strain
found
produc
antibodi
studi
also
strain
suscept
cmvinduc
vascular
diseas
berencsi
et
al
hamamdz
et
al
presti
et
al
fact
cmv
induct
antibodi
reproduc
mice
make
possibl
examin
whether
antibodi
play
part
cmvinduc
vascular
patholog
cell
medium
antibodi
fac
immunoblot
nih
nih
cell
obtain
atcc
rockvil
md
grown
recommend
mous
embryo
fibroblast
prepar
balbc
mous
embryo
describ
brune
et
al
cell
gener
provid
lab
vl
bautch
univers
north
carolina
chapel
hill
nc
propag
gelatinco
plate
biocoat
becton
dickenson
low
glucos
dmem
fetal
calf
serum
duboi
et
al
cell
grown
medium
contain
gibco
antibioticantimycot
solut
invitrogen
inc
two
antimurin
antibodi
use
rat
antimous
monoclon
research
diagnost
inc
rabbit
igg
santa
cruz
biotechnolog
inc
recombin
murin
cytomegaloviru
express
escherichia
coli
lacz
gene
gener
provid
edward
mocarski
stanford
univers
use
experi
viru
express
lacz
mid
late
infect
enzym
accumul
throughout
infect
stoddart
et
al
salivari
gland
passag
viru
prepar
describ
previous
hamamdz
et
al
titer
cell
plaqu
assay
perform
plate
briefli
nih
cell
plate
day
assay
cellswel
dilut
viru
made
minim
essenti
medium
contain
porcin
gelatin
al
dilut
viruswel
incub
cell
h
inoculum
aspir
cell
cover
alwel
methylcellulos
complet
medium
incub
h
al
neutralbuff
formalin
ad
well
min
follow
three
wash
phosphatebuff
salin
remov
methylcellulos
plaqu
visual
overlay
xgal
count
dissect
scope
inocul
mice
intraperiton
inject
salivari
glandpassag
viru
volum
ml
use
minim
essenti
medium
diluent
cyclosporin
purchas
lc
laboratori
woburn
mg
solubil
ml
ethanol
ml
tween
dilut
mgml
pb
inject
ethylenediaminetetraacet
acid
solut
ph
purchas
gibcobrl
cat
monohydr
p
lalaninepnitroanilid
hydrochlorid
purchas
sigma
cba
hybrid
mice
obtain
jackson
laboratori
bar
harbor
main
icr
mice
purchas
harlan
laboratori
experi
describ
studi
conform
bthe
guid
care
use
laboratori
animalsq
publish
us
nation
institut
health
nih
public
revis
approv
musc
institut
committe
care
use
laboratori
anim
food
water
provid
ad
libitum
mice
hous
hepafilt
cage
approv
anim
facil
monitor
daili
prepar
murin
small
intestin
nine
icr
mice
dissect
free
mesenter
fat
flush
clean
cold
salin
drain
tissu
homogen
volum
cold
sucros
buffer
mm
tri
ph
mm
sucros
tissum
tekmar
cincinnati
oh
min
keep
tube
ice
brush
border
membran
vesicl
format
induc
ad
cacl
final
concentr
mm
stir
continu
min
debri
pellet
centrifug
g
min
bbmv
pellet
centrifug
supernat
min
g
bbmv
resuspend
small
volum
sucros
buffer
store
gut
apn
shown
serolog
ident
express
splenocyt
macrophag
riemann
et
al
aminopeptidas
n
activ
assay
perform
incub
live
adher
cell
phosphatebuff
salin
ph
contain
mm
alaninepnitoanilid
hydrochlorid
absorb
read
interv
nm
elisa
perform
reactibind
maleic
anhydrid
activ
clear
plate
pierc
rockford
il
viral
antigen
elisa
intact
mcmv
grown
tissu
cultur
prepar
ultracentrifug
sucros
standard
protocol
brune
et
al
partial
purifi
viru
dilut
phosphatebuff
salin
protein
concentr
mgml
plate
coat
use
alwel
overnight
detect
antibodi
bbmv
sucros
buffer
dilut
pb
protein
concentr
mgml
alwel
use
coat
plate
overnight
block
bind
rabbit
antibodi
rat
monoclon
mous
sera
demonstr
specif
antibodi
sera
mcmvinfect
mice
apn
whole
cell
elisa
also
perform
measur
cell
surfac
express
murin
cell
line
cell
plate
cellswel
incub
antibodi
next
day
fixat
glutaraldehyd
horseradish
peroxidaseconjug
secondari
antibodi
use
detect
incub
abt
pierc
